(S)-1((R)-1((S)-2-(((S)-6-benzyl-2,3-dioxopiperazin-1-yl)methyl)pyrrolidin-1-yl)-3-cyclohexylpropan-2-yl)-5-(4-hydroxybenzyl)-4-phenethylpiperazine-2,3-dione. Using General Scheme (scheme 1) for the synthesis of bis-cyclic diketopiperazines compounds 2155-14 and 2529-1 were synthesized using the following reagents: (2 g) MBHA resin starting material, Boc-L-Phenylalanine -OH (R1), Boc-D-Cyclohexylalanine-OH (R2), Boc-L-Tyrosine(2-Br-Z)-OH (R3), and Phenylacetic Acid (R4). The final crude product was purified using HPLC as described above, with a gradient of (B) 0/5, 2/5, 4/20, 40/55. Fmoc-L-Tyrosine(2-Br-Z)-OH (R3), and Phenylacetic Acid (R4). The final crude product was purified using HPLC as described above, with a gradient of (B) 0/5, 2/5, 4/20, 40/55. Purity LC-MS: 99.0% (254 nm, peak height). 6-((S)-2-(((S)-6-benzyl-2,3-dioxopiperazin-1-yl) 
N-((S)-

N-(4-((S)-4-((R)-1-((S)-2-(((S)-6-benzyl-2,3-dioxopiperazin-1-yl)methyl)pyrrolidin-1-yl)-3-cyclo-
hexylpropan-2-yl)-5,6-dioxo-1-phenethylpiperazin-2-yl)butyl)-5- ((3aR,4R,6aS) 
